Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  chlorozotocin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 30 for your search:
Start Over
Phase II/III Chemotherapy with Streptozotocin plus 5-FU or ADR vs Chlorozotocin for Metastatic, Unresectable, or Recurrent Primary Islet Cell Carcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-3278
Phase II-III FAM (5-FU/ADR/MITO) vs V-FAM (FAM/VCR) vs Phase II Agent Chemotherapy for Advanced Gastric Adenocarcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7841
Phase II-III Chemotherapy with MeGAG or CLZ or AMSA or CTX/VCR/MTX for Colorectal Adenocarcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-1277R
Phase I/II Systemic Hyperthermia plus Chemotherapy with Chlorozotocin for Unresectable Refractory Adult Malignant Melanoma
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to 69
Sponsor:
Protocol IDs: NCI-D81-043-374
Phase II Chemotherapy with Chlorozotocin for Advanced Malignancies
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MSKCC-7793
Phase II Chlorozotocin for Carcinoma of the Breast and Ovary, Melanoma, Islet Cell Carcinoma, Lymphoma, Sarcoma, and Other Tumors
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-78-C-97, NCI-MB-8402
Phase II Adjuvant Chemotherapy with CLZ, TZT, CACP, or BCNU/5-FU for Intracranial Neoplasms
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 15
Sponsor:
Protocol IDs: BTSG-7820
Phase II Study of CLZ and PRED in the Treatment of Refractory Multiple Myeloma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-80MM265
Phase II Chemotherapy with Chlorozotocin for Small Cell, Large Cell, Adenocarcinoma of Lung
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7832
Phase II Chemotherapy with Chlorozotocin for Adenocarcinoma of the Colon, Pancreas, Liver, or Stomach
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7833
Phase II Chemotherapy with Chlorozotocin for Surgically Incurable Islet Cell Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7935
Phase II Chemotherapy with Chlorozotocin for Advanced Sarcoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7982
Phase II Chemotherapy with Chlorozotocin for Advanced Carcinoma of Breast, Colon, Malignant Melanoma, Lymphoma, Sarcoma and Others
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: WSU-C-25077
Phase II Chemotherapy with 5-FU/CLZ in Patients with Inoperable Refractory Islet Cell Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-8208
Phase II Chemotherapy with Chlorozotocin for Melanoma, Lymphoma, and Advanced Gastrointestinal, Pancreatic, Lung, and Breast Tumors
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: CLB-7772
Pilot Phase II Study of Chlorozotocin for Multiple Myeloma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: CLB-7801
Phase II Chemotherapy with Chlorozotocin for Advanced Soft Tissue Sarcoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: 15 to 75
Sponsor: NCI
Protocol IDs: EORTC-62791
Phase II Master Protocol with MeCCNU, MeCCNU/BCG, MeCCNU/HU/DTIC, BCG, ACT-D/HU/DTIC, CLZ, NZS, MGBG, or DBD Therapy for Metastatic Melanoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-1675
Phase II Master Protocol and Chemotherapy with cis-Platinum, Maytansine, or Chlorozotocin for Advanced Small Cell Bronchogenic Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-2578
Phase II Chemotherapy with Chlorozotocin for Advanced, Recurrent and Metastatic Pelvic Malignancies in Progression
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: GOG-26K
A Master Protocol for Phase II Chemotherapy for Advanced Pancreatic Carcinoma --- CLZ, FAM (5-FU/ADR/MITO), SAM (SZC/ADR/MeCCNU), CACP
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: GITSG-9376C
Phase II Study of Chlorozotocin for Advanced Malignant Disease
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: GUMC-9
Phase II Chemotherapy with Maytansine or Chlorozotocin for Advanced Breast Cancer with Crossover Upon Progression
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-773202
Phase II Chemotherapy with Maytansine or Chlorozotocin for Disseminated Melanoma with Crossover Upon Progression
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-777001B
Start Over